PMV Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
PMV Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q3 2024.
  • PMV Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.22M, a 33.1% decline year-over-year.
  • PMV Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $10.6M, a 15.2% decline year-over-year.
  • PMV Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $12.4M, a 21.4% increase from 2022.
  • PMV Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.2M, a 90.9% increase from 2021.
  • PMV Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.34M, a 176% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $10.6M $2.22M -$1.1M -33.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $11.7M $2.77M -$386K -12.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $12.1M $2.61M -$322K -11% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $12.4M $2.97M -$86K -2.82% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $12.5M $3.32M +$876K +35.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $11.6M $3.15M +$635K +25.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $11M $2.93M +$755K +34.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $10.2M $3.05M +$1.29M +72.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $8.91M $2.45M +$652K +36.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $8.26M $2.52M +$1.37M +119% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $6.89M $2.18M +$1.55M +247% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $5.34M $1.77M +$1.18M +203% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $4.16M $1.8M +$1.13M +168% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $3.03M $1.15M +$767K +200% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $2.26M $627K +$331K +112% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $1.93M $584K Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $670K +$431K +180% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $383K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $296K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q3 2019 $239K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.